Fora Capital, LLC Fate Therapeutics Inc Put Options Transaction History
Fora Capital, LLC
- $903 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FATE
# of Institutions
144Shares Held
96MCall Options Held
56.7KPut Options Held
5.4K-
Redmile Group, LLC San Francisco, CA12.9MShares$15.7 Million1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$12.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$12.3 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY7.79MShares$9.51 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.29MShares$5.23 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $118M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...